American Society of Clinical Oncology

SHERPA: White

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Noy
    Noy
  4. Palomba
    Palomba
  5. Moskowitz
    Moskowitz
  6. Hamlin
    Hamlin
  7. Yahalom
    Yahalom
  8. Schoder
    Schoder
  9. Kumar
    Kumar
  10. Vardhana
    Vardhana

Groups

  1. Center for Hematologic Malignancies (278)
  2. Department of Medicine (278)
  3. Hematologic Malignancies, Division of (278)
  4. Lymphoma (278)
  5. Population Sciences Research Program (76)
  6. Survivorship Research (62)
  7. Epidemiology and Biostatistics (34)
  8. Executive Committee, Center for Hematologic Malignancies (29)
  9. Solid Tumor Oncology Division (27)
  10. GSK Faculty (25)
Search Within
  1. "Lymphoma"
  2. "Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (169)
  2. Journal Article (102)
  3. Review (3)
  4. Editorial (2)
  5. Correspondence (1)
  6. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (278)
  2. Department of Medicine (278)
  3. Hematologic Malignancies, Division of (278)
  4. Lymphoma (278)
  5. Population Sciences Research Program (76)
  6. Survivorship Research (62)

More Groups

People
  1. Andrew Zelenetz (84)
  2. Steven Horwitz (62)
  3. David Straus (45)
  4. Ariela Noy (41)
  5. Paul Hamlin (39)
  6. Matthew Matasar (37)

More People

Years
  1. 2024 (1)
  2. 2023 (8)
  3. 2022 (13)
  4. 2021 (15)
  5. 2020 (16)
  6. 2019 (23)

More Years

Publications
  1. Journal of Clinical Oncology (264)
  2. Journal of Oncology Practice (8)
  3. American Society of Clinical Oncology Educational Book (5)
  4. JCO Clinical Cancer Informatics (1)

Results (278)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prediagnosis cardiovascular risk and subsequent myocardial infarction (Ml) among lymphoma survivors
    Meeting Abstract

    Salz, T.; Zabor, E. C.; de Nully Brown, P.; Dalton, S. O.; Raghunathan, N. J.; Matasar, M. J.; Steingart, R.; Hjalgrim, H.; Specht, L.; Oeffinger, K. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 1 study of CA-4948, a novel inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) in patients (pts) with r/r non-Hodgkin lymphoma
    Meeting Abstract

    Rosenthal, A. C.; Tun, H. W.; Younes, A.; Nowakowski, G. S.; Lunning, M. A.; Patel, K.; Landsburg, D. J.; Martell, R. E.; Leslie, L. A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Real-world assessment of practice efficiency with the introduction of subcutaneous rituximab
    Meeting Abstract

    Qiu, A.; Shapouri, S.; Drill, E. N.; Schade, J.; Ravelo, A.; Ni, A.; To, T. M.; Dawson, K. L.; Matasar, M. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Response to brentuximab vedotin by CD30 expression: Results from five trials in PTCL, CTCL, and B-cell lymphomas
    Meeting Abstract

    Jagadeesh, D.; Horwitz, S. M.; Bartlett, N. L.; Advani, R. H.; Jacobsen, E. D.; Duvic, M.; Gautam, A.; Rao, S.; Onsum, M.; Fanale, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants
    Meeting Abstract

    Ghione, P.; Cordeiro, P. G.; Ni, A.; Hu, Q. Y.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Managing cytokine release syndrome (CRS) and neurotoxicity with step-fractionated dosing of mosunetuzumab in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Bartlett, N. L.; Sehn, L. H.; Assouline, S. E.; Bosch, F.; Diefenbach, C. S. M.; Flinn, I.; Hong, J.; Kim, W. S.; Matasar, M. J.; Nastoupil, L. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Response to A+CHP by CD30 expression in the ECHELON-2 trial
    Meeting Abstract

    Advani, R. H.; Horwitz, S. M.; Iyer, S. P.; Bartlett, N. L.; Kim, W. S.; Tilly, H.; Belada, D.; Feldman, T.; IlleĢs, A.; Jacobsen, E. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel (liso-cel) treatment of patients (pts) with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) and secondary CNS lymphoma: Initial results from TRANSCEND NHL 001
    Meeting Abstract

    Abramson, J. S.; Palomba, M. L.; Arnason, J. E.; Lunning, M. A.; Solomon, S. R.; Farazi, T.; Garcia, J.; Xie, B.; Newhall, K. J.; Dehner, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Reply to M. Skelin et al
    Correspondence

    Wilson, W. H.; Staudt, L.; Younes, A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: Clinical outcomes of the phase III intergroup trial alliance/CALGB 50303
    Journal Article

    Bartlett, N. L.; Wilson, W. H.; Jung, S. H.; Hsi, E. D.; Maurer, M. J.; Pederson, L. D.; Polley, M. Y. C.; Pitcher, B. N.; Cheson, B. D.; Kahl, B. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save